Navigation Links
VetCentric Announces Partnership With Pfizer Animal Health

GLEN BURNIE, Md., Feb. 15 /PRNewswire/ -- VetCentric, Inc., the nation's largest practice-to-home delivery provider of prescription medications and veterinary therapeutic and wellness diets, announced today a partnership with Pfizer Animal Health, opening up the full suite of Pfizer products to VetCentric's partner clinics for home delivery. Pfizer Animal Health is the world's leader in the discovery, development and manufacture of veterinary-prescription vaccines and medicines for livestock and companion animals worldwide.

"We are excited about this agreement and what it means for our partner clinics," says Ted Root, President and CEO of VetCentric. "In addition to expanding access to the complete Pfizer product line, we are pleased that our clinics now can be assured of the full-manufacturer's guarantee for all of their home delivery products fulfilled by VetCentric."

Veterinarians partner with VetCentric for many reasons, including the company's ability to increase patient compliance on average over 200%. This increased compliance results in more successful therapeutic results. This partnership further substantiates VetCentric's commitment to supporting the veterinary industry and its recognition that VetCentric only deals with partner veterinarians where there is a validated Vet-Client-Patient Relationship (VCPR).

About VetCentric:

VetCentric, Inc., a privately-held company headquartered in the Baltimore-Washington area, is the only national veterinary-focused pharmacy offering home delivery of FDA and EPA approved pharmaceuticals, compounded medications and diets to pet owners on behalf of veterinary clinics.  Its comprehensive suite of services provides clinics with an online store that allows customized product selection and pricing, home delivery and client communication services.  VetCentric firmly supports the Veterinarian-Client-Patient relationship in all its business practices, allowing veterinarians to stay at the center of their patients' care while improving service, encouraging compliance and decreasing clinic operating costs. 

In the past 10 years, VetCentric has partnered with thousands of veterinary clinics to fill in excess of 2.5 million prescriptions for nearly 500,000 pet owners.  Its pharmacy complies with the licensing and inspection requirements of all states in which it does business. For more information, please visit

SOURCE VetCentric, Inc.



SOURCE VetCentric, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. VetCentric and ImproMed, Inc.(R) Announce One-Click Home Delivery Integration
2. VetCentric Partners With Hills Pet Nutrition
3. Albemarle(R) Announces Custom Manufacturing Alliance with PharmaCore(R)
4. OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
5. Health Robotics Announces Successful Transition to new and Distinctively Superior Distribution Channels in North America
6. Amnis Announces Record 2009 Sales
7. Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010
8. The American Academy of Pain Medicine Announces this Years Presidential Commendations and Awards
9. CORD:USE Cord Blood Bank Announces Partnership with Memorial Healthcare System
10. Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma
11. Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
Post Your Comments:
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
(Date:12/1/2015)... ANGELES , Dec. 1, 2015 CytRx ... development company specializing in oncology, today announced that it ... the company,s pivotal global Phase 3 clinical trial of ... (STS). Enrollment was originally estimated to be completed in Q1 ... being conducted under a Special Protocol Assessment from the ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration to ... develop shared care plans that help patients stay ... plans will be digitally enabled, incorporate care guidelines ... and desires. They will also allow all stakeholders ... health journey is optimal. That is the vision, ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 01, 2015 , ... Physicians’ Education Resource®, LLC (PER®) ... announced that the first annual School of Gastrointestinal Oncology™ (SOGO™) will be held ... treatment of gastrointestinal cancers are undergoing transformational change, providing oncologists with powerful new ...
(Date:12/1/2015)... ... December 01, 2015 , ... Speech and ... believe that with innovative technologies and under the right circumstances, these practices can ... benefit of a dual-approach to his or her therapeutic sessions, as well as ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... the 7th Annual 2015 Golden Bridge Business Awards under the New Products and ... zero capex web based sample management software that helps labs organize ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric ... the focus of numerous abstracts accepted for presentation here, at the 101st Annual ... abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools for ...
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. ... that the organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior ... award celebrates exceptional special needs providers that excel in synthesizing the areas of ...
Breaking Medicine News(10 mins):